AzTrials
AzTrials

Dental Caries in ChildrenPhase 4NCT04887389

Cariostatic and Remineralizing Effects of Three Different Dental Varnishes

A Phase 4 study testing Nano Silver Fluoride varnish, nano-hydroxyapatite varnish and sodium Fluoride Varnish in people with Dental Caries in Children and Cariostatic Agent, run by Nisreen Ibrahim khan at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a randomly, controlled, prospective in vivo study. The objective of this study is: To evaluate the cariostatic and re-mineralizing effects of Nano silver fluoride, Nano Hydroxyapatite and sodium fluoride varnishes in caries prevention through: 1. Read more about this study

Who is it for?
Ages 7 to 10 yearsHealthy volunteers can take part
What is being tested?
Nano Silver Fluoride varnish, nano-hydroxyapatite varnish and sodium Fluoride Varnish
Could I receive a placebo?
No, everyone receives an active treatment
How many people
115 participants
Where
1 siteEgypt
Study dates
1 Aug 2021to 1 Feb 2023
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • The inclusion criteria of participated children :
  • Age rang 7-10 years.
  • Teeth with score 0, 1 or 2 according to (international caries detection and assessment system) ICDAS II index.
  • Patient did not receive any re-mineralizing agent other than the regular toothpaste during the past three months.
  • No known history of allergy against silver particles or colophonium.
  • written informed consent from the parents/guardians.

Who cannot join

  • <!-- -->
  • Teeth with score 3 or more according to ICDAS II index.
  • Partially erupted permanent teeth.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry / Mansoura University

    Al Mansurah, Dakahlia Governorate, 35511

Other trials in Egypt

About this study

Official title: Cariostatic and Remineralizing Effects of Three Different Dental Varnishes (A Clinical Trial)

This study is a randomly, controlled, prospective in vivo study.

The objective of this study is:

To evaluate the cariostatic and re-mineralizing effects of Nano silver fluoride, Nano Hydroxyapatite and sodium fluoride varnishes in caries prevention through:

  1. Clinical evaluation using international caries detection and assessment system (ICDAS II visual scoring criteria)
  2. Calcium and fluoride content using enamel biopsy
Read the detailed description

Dental caries is a chronic, multi factorial, transmissible, infectious disease. Caries prevalence in young children in Egypt is very high, and most of the decayed teeth are left untreated, The increase prevalence of dental caries in children globally and in developing countries such as Egypt particularly makes the need for preventive treatment is necessary, one of the ways to prevent dental caries is the application of fluoride which can prevent dental caries by inhibiting demineralization of the crystal structures inside the tooth and enhancing remineralization.

Subsequently over the years various topical fluoride agents have been evolved but NaF (a 22,600 ppm F- preparation) is the most commonly used agent, Based on systematic studies, 5% NaF varnish was more effective in re-mineralizing early enamel caries.

Another anti caries product is a nano-hydroxyapatite (n-HAP), it has antibacterial effect, higher solubility, surface energy and bio activity, there are several studies concluded that 10% (n-HAP) may be optimal for remineralization of early enamel caries Nano-Silver Fluoride (NSF) is a new experimental formulation containing silver nanoparticles, it was introduced by Targino AG et al.(2014) to combat the problem of black discoloration of Silver Diamine Fluoride. It is safe to be used in humans and has effective antimicrobial properties against the pathogens responsible for the development of dental caries.

most of the studies have been evaluated the effectiveness of anti-caries agent in In Vitro and to the best of our knowledge, there are no published studies in Egypt on the effectiveness of these agent. As such, due to the continuous development of new remineralizing agents, research is needed to investigate the newer remineralizing agents under different circumstances. The present study will be carried out to evaluate the efficacy of Nano silver fluoride, Nano Hydroxyapatite and Sodium fluoride varnishes in caries prevention.

Being tested
Nano Silver Fluoride varnish, nano-hydroxyapatite varnish, sodium Fluoride Varnish
Keywords
Dental caries prevention, NSF (nano silver fluoride), n-HAP (Nano hydroxyapatite ), NaF ( Sodium Fluoride), ICDAS II, Enamel biopsy
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nano Silver Fluoride varnishDrug

    Also called ( NSF)

    Nano Silver Fluoride(5%) is a new experimental formulation containing silver nanoparticles, chitosan and fluoride combines preventive and antimicrobial properties. It is a yellow solution and safe to be used in humans

  • nano-hydroxyapatite varnishDrug

    Also called (n-HAP)

    nano-hydroxyapatite (10%) has antibacterial effect, higher solubility, surface energy and bioactivity and its structure is similar to dental apatite.

  • sodium Fluoride VarnishDrug

    Also called NaF

    Fluoride varnish (5%) applied every six months is effective in preventing caries in the primary and permanent dentition of children and adolescents

Study groups in NCT04887389
Study groupRoleWhat they receive
Group of • Nano Silver Fluoride varnish ( NSF)ExperimentalSelected children will be divided randomly into three groups: Group 1: Children receiving Nano Silver Fluoride varnish (NSF) (n =50).
Receives: Drug: Nano Silver Fluoride varnish
group of Nano hydroxyapatite varnish (n-HAP)ExperimentalGroup 2 Children receiving Nano-hydroxyapatite varnish (n = 50)
Receives: Drug: nano-hydroxyapatite varnish
group of Sodium Fluoride Varnish (NaF)ExperimentalGroup 3: Children receiving Sodium Fluoride Varnish (n = 50)
Receives: Drug: sodium Fluoride Varnish

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. a. Clinical evaluation using international caries detection and assessment system (ICDAS II visual scoring criteria

    After taking the personal data of the participant, dental examination will be conducted by one trained and calibrated examiner under the standard situation including semi-supine position of the subject, good illumination and taking into account all methods of infection control.

    Baseline dental examination for all surfaces of included teeth according to ICDAS II was recorded. Only the surfaces with 0, 1 and 2 score will be included in the follow up assessment (Drying of the tooth surface is the key for detecting non-cavitated lesions).

    Diagnostic criteria for newly dental caries :

    In order to compare the preventive efficacy of the three preventive agent, any change in the baseline recording of score 0, 1, or 2 will be recorded in each visit of all three groups, and an comparison will be made between the mean of tooth surfaces with score 0, 1 or 2 in the baseline visit and during all follow-up visits in each group and after that comparing among all groups.

    Measured: 1. All children will be assessed clinically in four visits along one year, at the baseline as well as at 3rd, 6th and 12th month of follow up visit

  2. Enamel biopsy for detecting Calcium and Fluoride content .

    The tooth on which the biopsy had to be done will be isolated with the help of cotton rolls and high volume suction to eliminate any chances of saliva contamination. Sticking plaster will be used to cover the tooth to be subjected for biopsy. A 6 mm circular punch will be made in the sticking plaster keeping in mind that it should be present on the buccal surface of molar. A 6 mm non-fluoride containing circular blotting paper will wetted with 5 µL of 30% phosphoric acid and immediately placed on the punched window for 4 s . This filter paper will then transferred to plastic tube which had 0.1 ml of double distilled water pipetted using a micro-pipette. Equal amount of total ionic strength adjustment buffer (TISAB-II) will added using a micropipette to the plastic tube, after which it will be stored for 3 days. After that it will send to laboratory for fluoride and calcium analysis.At the end -fluoride varnish will be applied to the surface.

    Measured: Fluoride and calcium content will be evaluated at the baseline as well as at the last follow-up visit through study completion, an average of 1 year"

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2021
  2. Study start1 Aug 2021
  3. Primary completion1 Sep 2022
  4. Study completion1 Feb 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Selected children will be divided randomly into three groups: * Group 1: Children receiving Nano Silver Fluoride varnish (NSF) (n =39). * Group 2 Children receiving Nano-hydroxyapatite varnish (n = 37). * Group 3: Children receiving Sodium Fluoride Varnish (n = 39) Procedure for material application The application of single drop (0.1 mL) of either (5%) NSF, (10%) n-HAP, (5%) NaF varnishes with a disposable micro-applicator tip for 10 seconds. NSF will be used in a single application and no repetition. While n-HAP, NaF varnishes will be applied each 6 months .
Masking
None (open label)
Enrolment
115 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04887389
Sponsor's protocol ID
A07071020
Status last verified
Jun 2022
First submitted
5 May 2021
Last updated
2 Apr 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Abbass MMS, Mahmoud SA, El Moshy S, Rady D, AbuBakr N, Radwan IA, Ahmed A, Abdou A, Al Jawaldeh A. The prevalence of dental caries among Egyptian children and adolescences and its association with age, socioeconomic status, dietary habits and other risk factors. A cross-sectional study. F1000Res. 2019 Jan 3;8:8. doi: 10.12688/f1000research.17047.1. eCollection 2019.

    PubMed 30854195
  • Azarpazhooh A, Main PA. Fluoride varnish in the prevention of dental caries in children and adolescents: a systematic review. Tex Dent J. 2008 Apr;125(4):318-37. No abstract available.

    PubMed 18491761
  • Chu CH, Mei ML, Lo EC. Use of fluorides in dental caries management. Gen Dent. 2010 Jan-Feb;58(1):37-43; quiz 44-5, 79-80.

    PubMed 20129891
  • Huang SB, Gao SS, Yu HY. Effect of nano-hydroxyapatite concentration on remineralization of initial enamel lesion in vitro. Biomed Mater. 2009 Jun;4(3):034104. doi: 10.1088/1748-6041/4/3/034104. Epub 2009 Jun 5.

    PubMed 19498220
  • Pepla E, Besharat LK, Palaia G, Tenore G, Migliau G. Nano-hydroxyapatite and its applications in preventive, restorative and regenerative dentistry: a review of literature. Ann Stomatol (Roma). 2014 Nov 20;5(3):108-14. eCollection 2014 Jul.

    PubMed 25506416
  • Targino AG, Flores MA, dos Santos Junior VE, de Godoy Bene Bezerra F, de Luna Freire H, Galembeck A, Rosenblatt A. An innovative approach to treating dental decay in children. A new anti-caries agent. J Mater Sci Mater Med. 2014 Aug;25(8):2041-7. doi: 10.1007/s10856-014-5221-5. Epub 2014 May 13.

    PubMed 24818873

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Nano Silver Fluoride varnish, nano-hydroxyapatite varnish and sodium Fluoride Varnish in people with Dental Caries in Children and Cariostatic Agent, run by Nisreen Ibrahim khan at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

a. Clinical evaluation using international caries detection and assessment system (ICDAS II visual scoring criteria (time frame: 1. All children will be assessed clinically in four visits along one year, at the baseline as well as at 3rd, 6th and 12th month of follow up visit). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04887389, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in